Skip to main content
logo
Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.2200
+0.0105 (5.01%)
Oct 29, 2025, 3:20 PM EDT

Kelyniam Global Revenue

In the year 2023, Kelyniam Global had annual revenue of $2.67M, down -11.44%. Kelyniam Global had revenue of $930.77K in the quarter ending December 31, 2023, with 14.08% growth.

Revenue
2.67M
Revenue Growth
-8.03%
P/S Ratio
4.14
Revenue / Employee
133.62K
Employees
20
Market Cap
11.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20232.67M-345.24K-11.44%
Dec 31, 20223.02M353.17K13.25%
Dec 31, 20212.66M152.33K6.06%
Dec 31, 20202.51M328.98K15.07%
Dec 31, 20192.18M59.43K2.80%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

Kelyniam Global News

More News